Showing results (51-60 of 115) with videos related to
Sort By:
Pageof 12
Alzheimer'S Research & Therapy|October 10, 2022
Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patientsJan Traub, Markus Otto, Roxane Sell, et al.Annals of Clinical and Translational Neurology|August 9, 2023
High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt-Jakob diseaseSamir Abu-Rumeileh, Steffen Halbgebauer, Giuseppe Mario Bentivenga, et al.Alzheimer'S Research & Therapy|November 24, 2022
Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer's and other neurodegenerative diseasesSteffen Halbgebauer, Petra Steinacker, Daniel Riedel, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 2, 2020
Cerebrospinal Fluid Levels of Prodynorphin-Derived Peptides are Decreased in Huntington's DiseaseMhd Rami Al Shweiki, Patrick Oeckl, Adrian Pachollek, et al.International Journal of Molecular Sciences|February 26, 2022
Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt-Jakob DiseaseSamir Abu-Rumeileh, Peggy Barschke, Patrick Oeckl, et al.Cell Death Discovery|March 13, 2025
TBK1 is involved in programmed cell death and ALS-related pathways in novel zebrafish modelsQuentin Raas, Gregoire Haouy, Hortense de Calbiac, et al.Translational Neurodegeneration|August 26, 2021
Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trialsSimon Witzel, Felix Frauhammer, Petra Steinacker, et al.Brain and Behavior|March 31, 2026
Association of Blood-Based Biomarkers and Malignant Infarction in Severe Anterior Circulation Ischemic StrokeDominik Lehrieder, Hermann Neugebauer, Alexander M Kollikowski, et al.Alzheimer'S Research & Therapy|January 2, 2020
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementiaSamir Abu-Rumeileh, Petra Steinacker, Barbara Polischi, et al.Scientific Reports|May 18, 2016
Modified serpinA1 as risk marker for Parkinson's disease dementia: Analysis of baseline dataSteffen Halbgebauer, Magdalena Nagl, Hans Klafki, et al.Pageof 12